Frank Takkinen
Stock Analyst at Lake Street
(1.12)
# 3,744
Out of 4,966 analysts
61
Total ratings
33.93%
Success rate
-14.11%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HYPR Hyperfine | Maintains: Buy | $1.5 → $2 | $1.24 | +61.29% | 2 | Aug 14, 2025 | |
| SGHT Sight Sciences | Upgrades: Buy | $3 → $5 | $4.06 | +23.15% | 5 | Aug 8, 2025 | |
| INSP Inspire Medical Systems | Maintains: Buy | $270 → $150 | $93.69 | +60.10% | 2 | Aug 5, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $12 → $8 | $1.71 | +367.84% | 2 | Jul 31, 2025 | |
| ANGO AngioDynamics | Initiates: Buy | $24 | $10.26 | +133.92% | 1 | Jul 16, 2025 | |
| BBNX Beta Bionics | Assumes: Buy | $30 | $18.84 | +59.28% | 1 | Jun 12, 2025 | |
| ELUT Elutia | Maintains: Buy | $10 → $8 | $2.28 | +250.88% | 3 | May 9, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $1.69 | +195.86% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $7.85 | +78.34% | 7 | Apr 8, 2025 | |
| LNSR LENSAR | Downgrades: Hold | $16 → $15 | $12.28 | +22.15% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $16.14 | +85.87% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $16.40 | +58.54% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $10.49 | +185.99% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $4.22 | +18.48% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.02 | +397.51% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.44 | +104.92% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.78 | +349.44% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $43.93 | -31.71% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.23 | +387.80% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.88 | +38.89% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $9.15 | +31.15% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $1.99 | +352.26% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.26 | +607.96% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.49 | +1,802.70% | 2 | Jan 18, 2023 |
Hyperfine
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.24
Upside: +61.29%
Sight Sciences
Aug 8, 2025
Upgrades: Buy
Price Target: $3 → $5
Current: $4.06
Upside: +23.15%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $93.69
Upside: +60.10%
Pulmonx
Jul 31, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $1.71
Upside: +367.84%
AngioDynamics
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $10.26
Upside: +133.92%
Beta Bionics
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $18.84
Upside: +59.28%
Elutia
May 9, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $2.28
Upside: +250.88%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $1.69
Upside: +195.86%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $7.85
Upside: +78.34%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $12.28
Upside: +22.15%
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $16.14
Upside: +85.87%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $16.40
Upside: +58.54%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $10.49
Upside: +185.99%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $4.22
Upside: +18.48%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $4.02
Upside: +397.51%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.44
Upside: +104.92%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.78
Upside: +349.44%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $43.93
Upside: -31.71%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.23
Upside: +387.80%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.88
Upside: +38.89%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $9.15
Upside: +31.15%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $1.99
Upside: +352.26%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.26
Upside: +607.96%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.49
Upside: +1,802.70%